← FDA Drug Approvals (Drugs@FDA)

QNASL

NDA · New Drug Application · Sponsor: TEVA BRANDED PHARM · Approved 2012-03-23

Drug application

FDA Application #

NDA202813

Application type

New Drug Application

Brand name

QNASL

Generic name

BECLOMETHASONE DIPROPIONATE

Active ingredients

BECLOMETHASONE DIPROPIONATE

Dosage form

AEROSOL, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

TEVA BRANDED PHARM

Manufacturer

Teva Respiratory, LLC

First approval

2012-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown